XML 26 R11.htm IDEA: XBRL DOCUMENT
v3.23.2

Supplemental Balance Sheet and Cash Flow Information | 12 Months Ended
--- | ---
Jun. 30, 2023
Notes to Financial Statements |
Supplemental Balance Sheet and Cash Flow Information | Note 3. Supplemental Balance Sheet and Cash Flow Information: Inventories: Inventories consist of (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | June 30,
​ |  | 2023 |  | 2022
​ | ​ | ​ | ​ | ​ | ​ | ​
Raw materials | ​ | $ | 84,551 | ​ | $ | 79,291
Finished goods(1) | ​ |  | 92,474 | ​ |  | 66,943
Inventories, net | ​ | $ | 177,025 | ​ | $ | 146,234
(1) | Finished goods inventory of $5,387 and $5,111 is included within other assets in the June 30, 2023 and June 30, 2022 Balance Sheets, respectively, as it is forecasted to be sold after the 12 months subsequent to the consolidated balance sheet date.
Property and Equipment: Property and equipment consist of (in thousands):
​ | ​ | ​ | ​ | ​ | ​
​ | June 30,
​ | 2023 |  | 2022
Land | $ | 9,100 | ​ | $ | 8,572
Buildings and improvements |  | 245,302 | ​ |  | 229,551
Machinery and equipment | ​ | 190,019 | ​ |  | 174,813
Construction in progress |  | 15,491 | ​ | ​ | 21,729
Property and equipment, cost |  | 459,912 | ​ |  | 434,665
Accumulated depreciation and amortization |  | (233,712) | ​ |  | (211,423)
Property and equipment, net | $ | 226,200 | ​ | $ | 223,242
​ Intangibles assets were comprised of the following (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | Useful Life | ​ | June 30,
​ | ​ | (years) | ​ | 2023 | ​ | 2022
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Developed technology |  | 9 - 15 | ​ | $ | 616,311 | ​ | $ | 542,038
Trade names |  | 2 - 20 | ​ |  | 146,945 | ​ |  | 146,457
Customer relationships |  | 7 - 16 | ​ |  | 213,878 | ​ |  | 225,882
Patents |  | 10 | ​ |  | 3,815 | ​ |  | 3,313
Other intangibles |  | 5 - 15 | ​ |  | 11,566 | ​ |  | 6,306
Definite-lived intangible assets | ​ | ​ | ​ |  | 992,515 | ​ |  | 923,996
Accumulated amortization | ​ | ​ | ​ |  | (480,570) | ​ |  | (415,174)
Definite-lived intangibles assets, net | ​ | ​ | ​ |  | 511,945 | ​ |  | 508,822
In process research and development | ​ | ​ | ​ |  | 22,700 | ​ |  | 22,700
Total intangible assets, net | ​ | ​ | ​ | $ | 534,645 | ​ | $ | 531,522
​ Changes to the carrying amount of net intangible assets consist of (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | June 30,
​ | ​ | 2023 | ​ | 2022
​ | ​ | ​ | ​ | ​ | ​ | ​
Beginning balance | ​ | $ | 531,522 | ​ | $ | 615,968
Acquisitions | ​ |  | 75,600 | ​ |  | —
Other additions(1) | ​ |  | 5,710 | ​ |  | 293
Amortization expense | ​ |  | (77,491) | ​ |  | (74,147)
Currency translation | ​ | ​ | (696) | ​ | ​ | (2,029)
Eminence impairment | ​ | ​ | — | ​ | ​ | (8,563)
Ending balance | ​ | $ | 534,645 | ​ | $ | 531,522
​ (1)Includes the purchase of a $4.6 million intangible asset from Wilson Wolf, an equity method investee of the Company during the year-ended June 30, 2023. This asset will be amortized over a life of 10 years. Amortization expense related to developed technologies included in cost of sales was $44.3 million, $40.6 million, and $36.5 million in fiscal 2023, 2022, and 2021, respectively. Amortization expense related to trade names, customer relationships, non-compete agreements, and patents included in selling, general and administrative expense was $33.2 million, $33.5 million, and $28.4 million, in fiscal 2023, 2022, and 2021 respectively. The estimated future amortization expense for intangible assets as of June 30, 2023, excluding any possible future amortization associated with acquired in-process research and development (IPR&D) which has not met technological feasibility, is as follows (in thousands):
​ | ​ | ​ | ​
2024 |  | $ | 75,331
2025 | ​ |  | 72,056
2026 | ​ |  | 68,089
2027 | ​ |  | 57,920
2028 | ​ |  | 54,470
Thereafter | ​ |  | 184,079
Total | ​ | $ | 511,945
​ Goodwill: ​ Changes in goodwill by segment and in total consist of (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | ​ |  | Diagnostics and |  | ​
​ | ​ | Protein Sciences | ​ | Genomics | ​ | Total
June 30, 2021 |  | $ | 392,717 | ​ | $ | 450,350 | ​ | $ | 843,067
Acquisitions | ​ |  | — | ​ | ​ | (4,407) | ​ |  | (4,407)
Eminence impairment | ​ | ​ | (8,275) | ​ | ​ | — | ​ | ​ | (8,275)
Currency translation | ​ |  | (7,949) | ​ | ​ | (335) | ​ |  | (8,284)
June 30, 2022 | ​ | $ | 376,493 | ​ | $ | 445,608 | ​ | $ | 822,101
Acquisitions | ​ |  | 51,257 | ​ | ​ | — | ​ | ​ | 51,257
Currency translation | ​ |  | (723) | ​ | ​ | 102 | ​ | ​ | (621)
June 30, 2023 | ​ | $ | 427,027 | ​ | $ | 445,710 | ​ | $ | 872,737
​ Other Assets: ​ Other assets consist of (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | June 30,
​ |  | 2023 | ​ | 2022
​ | ​ | ​ | ​ | ​ | ​ | ​
Investment in Wilson Wolf | ​ | $ | 255,857 | ​ | $ | 25,000
Derivative instruments | ​ | ​ | 16,857 | ​ | ​ | 11,026
Long-term inventory | ​ | ​ | 5,387 | ​ | ​ | 5,111
Other | ​ |  | 7,201 | ​ |  | 5,691
Other assets | ​ | $ | 285,302 | ​ | $ | 46,828
​ Supplemental Cash Flow Information: Supplemental cash flow information was as follows (in thousands):
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Year Ended June 30,
​ |  | 2023 |  | 2022 |  | 2021
Income taxes paid | ​ | $ | 88,428 | ​ | $ | 30,341 | ​ | $ | 20,952
Interest paid | ​ |  | 8,368 | ​ |  | 11,027 | ​ |  | 13,576
Non-cash activities: | ​ |  | ​ | ​ |  |  | ​ |  |
Acquisition-related liabilities (1) | ​ |  | 12,100 | ​ |  | 20,400 | ​ |  | 23,600
Other intangibles (2) | ​ |  | — | ​ |  | — | ​ |  | 4,000
(1) | Consists of holdback payments due at future dates and liabilities for contingent consideration. Amounts disclosed above represent the total non-cash change in the liability from the prior fiscal year. Further information regarding liabilities for contingent consideration can be found in Notes 4 and 5.
(2) | $4.0 million of the third party patented technology acquired in fiscal 2021 was a non-cash activity within the consolidated statement of cash flows as a cash payment was not made within the fiscal year ended June 30, 2021.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureTextBlockAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 210 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//210/tableOfContent + Details
Name: | us-gaap_SupplementalBalanceSheetDisclosuresTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration